Anticonvulsant drugs for management of cancer pain
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Anticonvulsant Drugs for Management of Cancer Pain." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454525/all/Anticonvulsant_drugs_for_management_of_cancer_pain.
Anticonvulsant drugs for management of cancer pain. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454525/all/Anticonvulsant_drugs_for_management_of_cancer_pain. Accessed October 24, 2019.
Anticonvulsant drugs for management of cancer pain. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454525/all/Anticonvulsant_drugs_for_management_of_cancer_pain
Anticonvulsant Drugs for Management of Cancer Pain [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454525/all/Anticonvulsant_drugs_for_management_of_cancer_pain.
TY - ELEC
T1 - Anticonvulsant drugs for management of cancer pain
ID - 454525
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454525/all/Anticonvulsant_drugs_for_management_of_cancer_pain
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine